Ardent Health (NYSE:ARDT) Shares Gap Down – Here’s What Happened

Ardent Health, Inc. (NYSE:ARDT) gapped down before the market opened on Monday . The stock had previously closed at $10.11, but opened at $9.66. Ardent Health shares last traded at $10.0950, with a volume of 17,088 shares trading hands.

Wall Street Analysts Forecast Growth

ARDT has been the subject of several recent analyst reports. UBS Group raised their target price on Ardent Health from $13.00 to $13.50 and gave the stock a “buy” rating in a research report on Thursday. Royal Bank Of Canada dropped their target price on shares of Ardent Health from $14.00 to $13.00 and set an “outperform” rating on the stock in a report on Monday, March 9th. JPMorgan Chase & Co. cut their price target on shares of Ardent Health from $12.00 to $11.00 and set a “neutral” rating for the company in a research note on Tuesday, January 20th. Zacks Research upgraded Ardent Health from a “strong sell” rating to a “hold” rating in a research note on Wednesday, March 25th. Finally, Leerink Partners dropped their target price on shares of Ardent Health from $16.00 to $15.00 and set an “outperform” rating for the company in a research note on Friday, March 6th. Seven investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, Ardent Health presently has a consensus rating of “Hold” and a consensus target price of $14.21.

Ardent Health Stock Performance

The stock has a 50 day moving average price of $9.26 and a two-hundred day moving average price of $9.75. The company has a current ratio of 2.12, a quick ratio of 2.00 and a debt-to-equity ratio of 0.62. The company has a market cap of $1.44 billion, a price-to-earnings ratio of 10.56, a P/E/G ratio of 2.25 and a beta of 0.93.

Ardent Health (NYSE:ARDT) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.28 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.18 by $0.10. The business had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.58 billion. Ardent Health had a return on equity of 13.85% and a net margin of 2.09%.Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. Analysts predict that Ardent Health, Inc. will post 1.12 EPS for the current year.

Institutional Trading of Ardent Health

Institutional investors have recently bought and sold shares of the business. Bank of New York Mellon Corp increased its holdings in Ardent Health by 4.2% in the 1st quarter. Bank of New York Mellon Corp now owns 241,052 shares of the company’s stock valued at $2,063,000 after buying an additional 9,743 shares during the period. Fifth Third Bancorp acquired a new stake in shares of Ardent Health during the first quarter worth $186,000. Hsbc Holdings PLC bought a new stake in shares of Ardent Health during the 1st quarter valued at about $175,000. R Squared Ltd bought a new stake in shares of Ardent Health during the 1st quarter valued at about $120,000. Finally, Abel Hall LLC bought a new stake in shares of Ardent Health during the 1st quarter valued at about $87,000.

Ardent Health Company Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.